Miura Partners acquires citrus flavonoid manufacturer HTBA
Spanish bioactives specialist HealthTech BioActives (HTBA) reports substantial growth over the past five years, with revenues reaching €80 million and workforce doubling to 200 employees. The Barcelona-based manufacturer of citrus flavonoids and vitamin B12 derivatives will now pursue further expansion under new majority shareholder Miura Partners.
